Cargando…
Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes
Using in vitro, in vivo and patient-based approaches, we investigated the potential of circulating microRNAs (miRNAs) as surrogate biomarkers of myocardial steatosis, a hallmark of diabetic cardiomyopathy. We analysed the cardiomyocyte-enriched miRNA signature in serum from patients with well-contro...
Autores principales: | de Gonzalo-Calvo, D., van der Meer, R. W., Rijzewijk, L. J., Smit, J. W. A., Revuelta-Lopez, E., Nasarre, L., Escola-Gil, J. C., Lamb, H. J., Llorente-Cortes, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428350/ https://www.ncbi.nlm.nih.gov/pubmed/28246388 http://dx.doi.org/10.1038/s41598-017-00070-6 |
Ejemplares similares
-
Expression of circulating microRNA-1 and microRNA-133 in pediatric patients with tachycardia
por: SUN, LING, et al.
Publicado: (2015) -
MicroRNA-133a and Myocardial Infarction
por: Xiao, Yi, et al.
Publicado: (2019) -
The Roles of MicroRNA-133 in Gynecological Tumors
por: Zhou, Yang, et al.
Publicado: (2022) -
microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers
por: Nohata, Nijiro, et al.
Publicado: (2012) -
MicroRNA Expression in Ileal Carcinoid Tumors: Down-regulation of MicroRNA-133a with Tumor Progression
por: Ruebel, Katharina, et al.
Publicado: (2009)